Loading market dashboard
Kezar Life Sciences, Inc.
KZRHealthcareNASDAQUS
Loading analysis workspace
Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
Kezar Life Sciences, Inc. · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2030 | $20.73M | $20.73M - $20.73M | $12.44M | -$6.10 | 1 |
| Dec 2029 | $19.97M | $19.97M - $19.97M | $11.98M | -$7.70 | 1 |
| Dec 2028 | $31.50M | $31.50M - $31.50M | $18.90M | -$7.45 | 1 |
| Dec 2027 | $21.00M | $21.00M - $21.00M | $12.60M | -$6.89 | 1 |
| Dec 2026 | $0.00 | $0.00 - $0.00 | $0.00 | -$4.93 | 0 |
| Dec 2025 | $4.00M | $4.00M - $4.00M | $2.40M | -$6.705 | 3 |
| Dec 2024 | $2.40M | $2.40M - $2.40M | $1.44M | -$5.765 | 3 |
| Dec 2023 | $7.00M | $7.00M - $7.00M | $4.20M | -$13.546 | 2 |